精神健康急性病患者航空医疗转运镇静方案并发症风险的回顾性队列研究
该回顾性队列研究纳入2011年1月1日至2022年12月31日由皇家飞行医生服务东南区(RFDSSE)执行的所有急性精神健康(AMH)患者航空医疗转运病例。将转运期间治疗符合RFDSSE精神健康转运方案(On Protocol,OnP)的患者与不符合方案(Off Protocol,OffP)者比较。85例中45.9%(n=39)符合方案。OffP组总体并发症更常见(54.3% vs 25.6%,差异28.7%,95%CI 7.8%至46.2%),严重并发症也更频繁(37.0% vs 5.1%,差异31.8%,95%CI 14.7%至46.7%)。插管患者(n=9,均在OffP组)严重并发症率最高为66.7%,接受咪达唑仑者(n=33,均在OffP组)严重并发症率为30.3%。作者认为氯胺酮是更安全的替代选择。
要点
- 在85例AMH航空转运中,仅45.9%(n=39)符合含氯胺酮镇静的转运方案。
- OffP组总体并发症54.3% vs OnP组25.6%,差异28.7%(95%CI 7.8%至46.2%)。
- OffP组严重并发症37.0% vs OnP组5.1%,差异31.8%(95%CI 14.7%至46.7%)。
- 插管患者(n=9,均在OffP组)严重并发症率66.7%;接受咪达唑仑者(n=33,均在OffP组)严重并发症率30.3%。
- 符合方案组无治疗失败或需插管事件;作者认为咪达唑仑和/或插管与更高并发症风险相关,氯胺酮是更安全的替代选择。
适用人群与场景
- 2011年1月1日至2022年12月31日期间由RFDSSE执行航空医疗转运的急性精神健康(AMH)患者。
- 纳入标准为所有AMH患者的航空医疗转运;按转运期间治疗是否符合RFDSSE精神健康转运方案分为OnP组和OffP组。
诊断标准与关键阈值
- 采用RFDSSE精神健康(MH)转运方案判定是否On Protocol(OnP);治疗与方案一致者为OnP,不一致者为Off Protocol(OffP)。
- 比较指标包括精神健康风险评估评分(MH risk assessment score)、转运时长、给予的药物及并发症(任何、严重)。
处置流程与药物剂量
- RFDSSE精神健康转运方案包括使用氯胺酮镇静。
- OffP组中部分患者接受了咪达唑仑(n=33)和/或插管(n=9)。
研究设计与关键结果
- 回顾性队列研究,纳入85例AMH航空医疗转运病例,其中45.9%(n=39)符合MH转运方案(OnP)。
- OffP组总体并发症发生率为54.3%,OnP组为25.6%,差异28.7%(95%CI 7.8%至46.2%)。
- OffP组严重并发症发生率为37.0%,OnP组为5.1%,差异31.8%(95%CI 14.7%至46.7%)。
- 插管患者(n=9,均在OffP组)严重并发症率最高为66.7%;接受咪达唑仑者(n=33,均在OffP组)严重并发症率为30.3%。
- OnP组无治疗失败或需插管事件。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在AMH患者航空医疗转运中采用包含氯胺酮镇静的方案化方法与更少总体并发症、更少严重并发症相关,且无治疗失败或需插管事件。
- 作者认为,在该队列中使用咪达唑仑和/或插管与更高并发症风险相关,氯胺酮是更安全的替代选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Aeromedical transfer of acutely unwell mental health (AMH) patients presents potential risks to patient, staff and aircraft. Pharmacological options to reduce risk can impair consciousness, risking airway compromise and management challenges in-flight. Pre-emptive intubation carries associated patient risks and requires a receiving intensive care unit bed. This study aimed to assess the risk of complications using a protocolised approach to sedation of AMH patients undergoing retrieval in New South Wales, Australia.
METHODS: This retrospective cohort study included all aeromedical transfers of AMH patients performed by the Royal Flying Doctor Service South Eastern Section (RFDSSE) between 1 January 2011 and 31 December 2022. AMH patients whose treatment during transfer aligned with the RFDSSE Mental Health (MH) transfer protocol ('On Protocol', OnP) were compared against the 'Off Protocol' (OffP) group. Patient characteristics (MH risk assessment score), transfer characteristics (duration), medications administered and complications (any, severe) experienced were compared using univariate analyses.
RESULTS: Treatment aligned with MH transfer protocol (ie, OnP) in 45.9% (n=39) of 85 cases. Complications were more common in the OffP group (54.3% vs 25.6%, a difference of 28.7% (95% CI 7.8% to 46.2%)). Similarly severe complications occurred more frequently in the OffP group (37.0% vs 5.1%, a difference of 31.8% (95% CI 14.7% to 46.7%)). Intubated patients (n=9, all OffP) had the highest rate of severe complications at 66.7%, followed by patients who received midazolam (n=33, all OffP), with a severe complication rate of 30.3%.
CONCLUSION: A protocolised approach to sedation of AMH patients undergoing aeromedical retrieval, including the use of ketamine sedation, was associated with fewer complications overall, fewer severe complications and no episodes of treatment failure or need for intubation. Our findings suggest that the use of midazolam and/or intubation in this cohort is associated with a higher risk of complications, and ketamine presents a safer alternative.
参考来源
- Lewis J, Perks A, Brendt P, et al. Risk of complications using a sedation protocol for aeromedical retrieval of acutely unwell mental health patients: a retrospective cohort study in Outback Australia. Emerg Med J. 2025. PMID: 40670080. doi:10.1136/emermed-2024-214719
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。